KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Cash from Operations: 2009-2025

Historic Cash from Operations for Neogenomics (NEO) over the last 17 years, with Sep 2025 value amounting to $8.9 million.

  • Neogenomics' Cash from Operations fell 3.92% to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.7 million, marking a year-over-year decrease of 8.80%. This contributed to the annual value of $7.0 million for FY2024, which is 459.60% up from last year.
  • Latest data reveals that Neogenomics reported Cash from Operations of $8.9 million as of Q3 2025, which was down 56.30% from $20.3 million recorded in Q2 2025.
  • In the past 5 years, Neogenomics' Cash from Operations registered a high of $20.3 million during Q2 2025, and its lowest value of -$29.0 million during Q1 2022.
  • For the 3-year period, Neogenomics' Cash from Operations averaged around $814,273, with its median value being $8.9 million (2025).
  • Per our database at Business Quant, Neogenomics' Cash from Operations crashed by 1,576.62% in 2021 and then surged by 997.42% in 2024.
  • Over the past 5 years, Neogenomics' Cash from Operations (Quarterly) stood at -$19.8 million in 2021, then surged by 81.37% to -$3.7 million in 2022, then surged by 582.61% to $17.8 million in 2023, then tumbled by 44.89% to $9.8 million in 2024, then dropped by 3.92% to $8.9 million in 2025.
  • Its Cash from Operations was $8.9 million in Q3 2025, compared to $20.3 million in Q2 2025 and -$25.3 million in Q1 2025.